Oragenics (OGEN) vs China SXT Pharmaceuticals (SXTC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Oragenics is the larger company by market cap ($708,377 vs $273,955), about 2.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | OGEN | SXTC |
|---|---|---|
| Share price | $0.157 | $2.65 |
| Market cap | $708.38K | $273.95K |
| 1-day change | -8.72% | +2.12% |
| EPS (TTM) | $-1.05 | $-73,040.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $1.14M |
| Revenue growth (YoY) | — | -34.63% |
| Net income (latest FY) | $-9.84M | $-6.21M |
| Gross margin | — | 21.85% |
| Operating margin | — | -625.89% |
| Net margin | — | -545.24% |
| 52-week high | $1.11 | $8,376,000.00 |
| 52-week low | $0.13 | $2.52 |
| Distance from 52-week high | -85.86% | -100.00% |
| Average volume | 849.30K | 234.25K |
| Shares outstanding | 4.51M | 103.58K |
| Employees | 3 | 56 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Oragenics is about 2.6 times larger than China SXT Pharmaceuticals by market value ($708.38K vs $273.95K).
About Oragenics
OGEN stock →Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification for the treatment of mild traumatic brain injury.
Health Care · Biotechnology: Pharmaceutical Preparations · 3 employees
About China SXT Pharmaceuticals
SXTC stock →China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers Advanced TCMP, including Directly-Oral-TCMP, and After-Soaking-Oral TCMP; Fine TCMP and Regular TCMP products; and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.
Health Care · Biotechnology: Pharmaceutical Preparations · 56 employees
OGEN vs SXTC FAQ
Which is bigger, Oragenics or China SXT Pharmaceuticals?
Oragenics (OGEN) is larger, with a market capitalization of $708.38K compared with $273.95K for China SXT Pharmaceuticals (SXTC).
Are Oragenics and China SXT Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.